Advanced Search

    column
    Consensus on Interpretation of Clinical Reports for Next-Generation Sequencing of Tumors
    The Oncology Expert Group on the Interpretation of Next Generation Sequencing Clinical Reports
    2022, 22(2): 65-79. DOI: 10.12019/j.issn.1671-5144.2022.02.001
    Abstract FullText HTML PDF
    Advances in the Treatment of Acute Myeloid Leukemia
    TANG Qing-hua, GONG Tie-jun, MA Jun
    2022, 22(2): 80-83. DOI: 10.12019/j.issn.1671-5144.2022.02.002
    Abstract FullText HTML PDF
    5-Year Follow-Up Results of CPX-351 Versus 7+3 Chemotherapy in Older Adults With Newly Diagnosed High-Risk or Secondary Acute Myeloid Leukaemia
    SHEN Heng, WEI Hui, TAN Jia-qi
    2022, 22(2): 84-86. DOI: 10.12019/j.issn.1671-5144.2022.02.003
    Abstract FullText HTML PDF
    Interpretation of the QUAZARAML-001 Clinical Study in the New Drug Era
    CHEN Xin-jie, ZHANG Su-jiang, WU Ping
    2022, 22(2): 87-90. DOI: 10.12019/j.issn.1671-5144.2022.02.004
    Abstract FullText HTML PDF
    Venetoclax Plus Low-Dose Cytarabine for Newly Diagnosed Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy
    ZHOU De, ZHU Hong-hu, CHEN Xiao-mei
    2022, 22(2): 91-94. DOI: 10.12019/j.issn.1671-5144.2022.02.005
    Abstract FullText HTML PDF
    A Promising Application Prospect, but It Still Has a Long Way to Go: Review on the Study of the Bispecific Antibody Flotetuzumab Targeting CD3 and CD123 in Relapsed/Refractory AML
    XU Kai-lin, ZHU Feng, WANG Jing-hua
    2022, 22(2): 95-97. DOI: 10.12019/j.issn.1671-5144.2022.02.006
    Abstract FullText HTML PDF
    Protective Effect and Mechanism of Ulinastatin on Acute Lung Injury in Septic Rats
    XIAO Jing, DONG Zhao-gang, ZUO Fang-tian, WEI Chao, ZHENG Xi-sheng, YANG Hong-fu
    2022, 22(2): 98-104. DOI: 10.12019/j.issn.1671-5144.2022.02.007
    Abstract FullText HTML PDF
    Explore and Analyze the Therapeutic Effects and Tumor Immune Microenvironment of Driver Gene-Positive Lung Squamous Cell Carcinoma
    GAO Qing-yun, LIN Xiao-cheng, CHEN Yu-qing, GAO Ling-ling, LI Yu-fa, ZHENG Ming-ying, PENG Kai-cheng, TAN Quan-quan, XIAO Fa-man, YANG Jin-ji
    2022, 22(2): 105-118. DOI: 10.12019/j.issn.1671-5144.2022.02.008
    Abstract FullText HTML PDF
    The Prognosis of Mutation of SWI/SNF Complex Subunits and the Relationship With Immune Markers in Advanced Non-Small Cell Lung Cancer
    JIANG Jie, GAO Ling-ling, CHEN Yu, ZHOU Wen-bin, CHEN Ji, YAN Wen-qing, LV Zhi-yi, LU Dan-xia, ZHANG Shui-lian, GUO Wei-bang, XIE Zhi, TIAN Hong-xia, HUANG Ying, ZHANG Xu-chao
    2022, 22(2): 119-125. DOI: 10.12019/j.issn.1671-5144.2022.02.009
    Abstract FullText HTML PDF
    Neoadjuvant Targeted Therapy for a Stage ⅢB Non-Small Cell Lung Cancer With ROS1 Rearrangements
    JIE Guang-ling, FU Rui, DONG Song
    2022, 22(2): 126-128. DOI: 10.12019/j.issn.1671-5144.2022.02.010
    Abstract FullText HTML PDF